Effect of haloperidol on mPer1 gene expression in mouse suprachiasmatic nuclei

Journal of Biological Chemistry

Volumn 280, Issue 8, 2005, Pages 6309-6315

  Viyoch, Jarupa ^a   Matsunaga, Naoya ^a   Yoshida, Miyako ^a   To, Hideto ^a   Higuchi, Shun ^a   Ohdo, Shigehiro ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BIOCHEMISTRY; DRUG DOSAGE; MOLECULAR BIOLOGY; PHASE SHIFT; PROTEINS; RNA;

GENE EXPRESSION; HALOPERIDOL (HAL); PHOSPHORYLATION; SUPRACHIASMATIC NUCLEI (SCN);

GENES;

ANTISENSE OLIGONUCLEOTIDE; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; DIZOCILPINE; HALOPERIDOL; MESSENGER RNA; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; SERINE; TRANSCRIPTION FACTOR;

ANIMAL CELL; ARTICLE; CIRCADIAN RHYTHM; CONTROLLED STUDY; DOPAMINERGIC SYSTEM; DOSIMETRY; GENE; GENE EXPRESSION; GENE INDUCTION; MALE; MOUSE; MPER1 GENE; NERVE CELL CULTURE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RECEPTOR UPREGULATION; SUPRACHIASMATIC NUCLEUS;

ANIMALS; CELL CYCLE PROTEINS; CELLS, CULTURED; CIRCADIAN RHYTHM; CYCLIC AMP RESPONSE ELEMENT-BINDING PROTEIN; DOPAMINE ANTAGONISTS; DRUG ADMINISTRATION SCHEDULE; GENE EXPRESSION REGULATION; HALOPERIDOL; MICE; MICE, INBRED ICR; NUCLEAR PROTEINS; PHOSPHORYLATION; RECEPTORS, N-METHYL-D-ASPARTATE; RNA, MESSENGER; SUPRACHIASMATIC NUCLEUS; UP-REGULATION;

EID: 14844283733     PISSN: 00219258     EISSN: None     Source Type: Journal    
DOI: 10.1074/jbc.M411704200     Document Type: Article

References (54)

1. Kako, K., and Ishida, N. (1998) Neurosci. Res. 31, 257-264
2. Sumova, A., Travnickova, Z., Mikkelsen, J. D., and Illnerova, H. (1998) Brain Res. 801, 254-258
3. Guido, M. E., Goguen, D., de Guido, L., Robertson, H. A., and Rusak, B. (1999) Neuroscience 90, 555-571
4. Hao, H., Allen, D. L., and Hardin, P. E. (1997) Mol. Cell. Biol. 17, 3687-3693
5. Dunlap, J. C. (1999) Cell 96, 271-290
6. Campbell, A., and Baldessarini, R. J. (1982) Psychopharmacology 77, 150-155
7. Nagayama, H., Takagi, A., and Takahashi, R. (1987) Experientia (Basel) 43, 625-626
8. Sirinathsinghji, D. J., Schuligoi, R., Heavens, R. P., Dixon, A., Iversen, S. D., and Hill, R. G. (1994) Neuroscience 62, 407-423D. J. S.F. J. H.
9. Robertson, G. S., Tetzlaff, W., Bedard, A., St-Jean, M., and Wigle, N. (1995) Neuroscience 67, 325-344
10. Palacios, G., Muro, M. A., and Marin, A. P., (1996) Brain Res. 742, 141-148
11. Sun, Y., Suzuki, M., Kurachi, T., Murata, M., and Kurachi, M. (1998) Brain Res. 791, 125-136
12. Suzuki, M., Sun, Y., Murata, M., and Kurachi, M. (1998) Psychiatry Clin. Neurosci. 52, 353-359
13. Albrecht, U., Sun, Z. S., Eichele, G., and Lee, C. C. (1997) Cell 91, 1055-1064
14. Shigeyoshi, Y., Taguchi, K., Yamamoto, S., Takekida, S., Yan, L., Tei, H., Moriya, T., Shibata, S., Loros, J. J., Dunlap, J. C., and Okamura, H. (1997) Cell 91, 1043-1053
15. Power, J. M., Ringo, J. M., and Dowse, H. B. (1995) J. Biol. Rhythms 10, 267-280
16. Zheng, B., Albrecht, U., Kaasik, K., Sage, M., Lu, W., Vaishnav, S., Li, Q., Sun, Z. S., Eichele, G., Bradley, A., and Lee, C. C. (2001) Cell 105, 683-694
17. Balsalobre, A., Damiola, F., and Schibler, U. (1998) Cell 93, 929-937
18. Yagita, K., and Okamura, H. (2000) FEBS Lett. 465, 79-82
19. Ohdo, S., Koyanagi, S., Suyama, H., Higuchi, S., and Aramaki, H. (2001) Nat. Med. 7, 356-360
20. Viyoch, J., Ohdo, S., Yukawa, E., and Higuchi, S. (2001) J. Pharmacol. Exp. Ther. 298, 964-969
21. Chartoff, E. H., Ward, R. P., and Dorsa, D. M. (1999) J. Pharmacol. Exp. Ther. 291, 531-537
22. Honma, S., Katsuno, Y., Tanahashi, Y., Abe, H., and Honma, K. (1998) Neuroscience 86, 967-976
23. Sato-Bigbee, C., and DeVries, G. H. (1996) J. Neurosci. Res. 46, 98-107
24. McNulty, S., Schurov, I. L., Sloper, P. J., and Hastings, M. H. (1998) Eur. J. Neurosci. 10, 1063-1072
25. Obrietan, K., Impey, S., Smith, D., Athos, J., and Storm, D. R. (1999) J. Biol. Chem. 274, 17748-17756
26. Travnickova, B. Z., Cermakian, N., Reppert, S. M., and Sassone, C. P. (2002) Proc. Natl. Acad. Sci. U. S. A. 99, 7728-7733
27. Hida, A., Koike, N., Hirose, M., Hattori, M., Sakaki, Y., and Tei, H. (2000) Genomics 65, 224-233
28. Hyttel, J., Larsen, J. J., and Christensen, A. V. (1995) Psychopharmacol 87, Suppl. 2, 9-18
29. Ohta, M. (1976) Physiol. Behav. 16, 505-507
30. Stool, J. C., and Tilders, F. J. (1989) in Dopamine Receptors in the Central Nervous System: The Role of Brain Dopamine (Fluckiger, E., Muller, E. E., and Thoner, M. O., eds) pp. 31-45, Springer Sandoz, Berlin
31. Tamminga, C. A., and Gerlach, J. (1987) in New Neuroleptics and Experimental Antipsychotics in Schizophrenia: Psychopharmacology, the Third Generation of Progress (Melzer, H. Y., ed) pp. 1129-1140, Raven Press, New York
32. Panda, S., Antoch, M. P., Miller, B. H., Su, A. I., Schook, A. B., Straume, M., Schultz, P. G., Kay, S. A., Takahashi, J. S., and Hogenesch, J. B. (2002) Cell 109, 307-320
33. Weiner, D. M., Levey, A. I., Sunahara, R. K., Niznik, H. B., O'Dowd, B. F., Seeman, P., and Brann, M. R. (1991) Proc. Natl. Acad. Sci. U. S. A. 88, 1859-1863
34. Pickard, G. E., and Rea, M. A. (1997) Biol. Cell 89, 513-523
35. Duncan, M. J., Jennes, L., Jefferson, J. B., and Brownfield, M. S. (2000) Brain Res. 869, 178-185
36. Weiland, N. G., and Wise, P. M. (1987) Endocrinology 121, 1751-1758
37. Gannon, R. L., and Rea, M. A. (1994) Brain Res. Mol. Brain Res. 23, 338-344
38. Leveque, J. C., Macias, W., Rajadhyaksha, A., Carlson, R. R., Barczak, A., Kang, S., Li, X. M., Coyle, J. T., Huganir, R. L., Heckers, S., and Konradi, C. (2000) J. Neurosci. 20, 4011-4020
39. Rajadhyaksha, A., Barczak, A., Macias, W., Leveque, J. C., Lewis, S. E., and Konradi, C. (1999) J. Neurosci. 19, 6348-6359
40. Schurov, I. L., Hepworth, T. J., and Hastings, M. H. (2002) Eur. J. Neurosci. 15, 223-232
41. Viswanathan, N., Weaver, D. R., Reppert, S. M., and Davis, F. C. (1994) J. Neurosci. 14, 5393-5398
42. Garcia-Sainz, J. A., and Villalobos, M. R. (2004) Eur. J. Pharmacol. 500, 113-120
43. Zhong, H., and Minneman, K. P. (1999) Eur. J. Pharmacol. 375, 261-276
44. Grewal, S. S., Fass, D. M., Yao, H., Ellig, C. L., Goodman, R. H., and Stork, P. J. (2000) J. Biol. Chem. 275, 34433-34441
45. Lesch, K. P. (2001) J. Affect. Disord. 62, 57-76
46. Sprouse, J., Reynolds, L., Li, X., Braselton, J., and Schmidt, A. (2004) Neuropharmacology 46, 52-62
47. Sprouse, J., Reynolds, L., Braselton, J., and Schmidt, A. (2004) Synapse 54, 111-118
48. Kumar, A., Chandra, O., and Saxena, P. N. (1981) Arzneim-Forsch. 31, 1096-1098
49. Colwell, C. S., Foster, R. G., and Menaker, M. (1991) Brain Res. 554, 105-110
50. Guido, M. E., de Guido, L., Goguen, D., Robertson, H. A., and Rusak, B. (1999) Brain Res. Mol. Brain Res. 67, 247-257
51. Moriya, T., Horikawa, K., Akiyama, M., and Shibata, S. (2000) Mol. Pharmacol. 58, 1554-1562
52. Mintz, E. M., Marvel, C. L., Gillespie, C. F., Price, K. M., and Albers, H. E. (1999) J. Neurosci. 19, 5124-5130
53. Mintz, E. M., Gillespie, C. F., Marvel, C. L., Huhman, K. L., and Albers, H. E. (1997) Neuroscience 79, 563-569
54. Akiyama, M., Kouzu, Y., Takahashi, S., Wakamatsu, H., Moriya, T., Maetani, M., Watanabe, S., Tei, H., Sakaki, Y., and Shibata, S. (1999) J. Neurosci. 19, 1115-1121